Cite
HARVARD Citation
Nam, J. et al. (2014). Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Annals of the rheumatic diseases. 73 (1), pp. 75-85. [Online].